Up to 20% of Americans have gastroesophageal reflux disease or GERD. Symptoms vary so diagnosing GERD accurately can be challenging. The director of UConn Health’s Esophageal Diseases Center, Dr. Houman Rezaizadeh, says the Bravo test can help pinpoint what’s going on and lead to appropriate, pain-relieving therapy.
UConn Health Minute: Diagnosing GERD
Up to 20% of Americans have gastroesophageal reflux disease or GERD. Symptoms vary so diagnosing GERD accurately can be challenging. The director of UConn Health’s Esophageal Diseases Center, Dr. Houman Rezaizadeh, says the Bravo test can help pinpoint what’s going on and lead to appropriate, pain-relieving therapy.
Dr. Houman Rezaizadeh, director of UConn Health's Esophageal Diseases Center, and gastroenterology fellow Dr. Xiang Liu discuss a case. (Tina Encarnacion/UConn Health photo)
